|
US6576239B1
(en)
|
1996-09-10 |
2003-06-10 |
The Burnham Institute |
Angiogenic homing molecules and conjugates derived therefrom
|
|
US6180084B1
(en)
|
1998-08-25 |
2001-01-30 |
The Burnham Institute |
NGR receptor and methods of identifying tumor homing molecules that home to angiogenic vasculature using same
|
|
GB9814527D0
(en)
*
|
1998-07-03 |
1998-09-02 |
Cyclacel Ltd |
Delivery system
|
|
IL142869A0
(en)
|
1998-11-13 |
2002-03-10 |
Cyclacel Ltd |
Transport vectors
|
|
FR2786397B1
(fr)
*
|
1998-11-30 |
2003-01-10 |
Synt Em |
Vecteurs peptidiques de substances a travers la barriere hematoencephalique pour etre utilises dans le diagnostic ou la therapie d'une affection du snc
|
|
FR2786398B1
(fr)
*
|
1998-11-30 |
2002-12-27 |
Synt Em |
Composition pharmaceutique anti-cancereuse et anti-chimioresistance comprenant un agent anticancereux et au moins un peptide
|
|
US6833373B1
(en)
|
1998-12-23 |
2004-12-21 |
G.D. Searle & Co. |
Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
|
|
US6858598B1
(en)
|
1998-12-23 |
2005-02-22 |
G. D. Searle & Co. |
Method of using a matrix metalloproteinase inhibitor and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
|
|
US6528481B1
(en)
|
1999-02-16 |
2003-03-04 |
The Burnam Institute |
NG2/HM proteoglycan-binding peptides that home to angiogenic vasculature and related methods
|
|
US6380161B1
(en)
|
1999-06-21 |
2002-04-30 |
Inkine Pharmaceutical Company, Inc. |
Compositions for treating chemotherapy-resistant tumor cells and targeted chemotherapy compositions
|
|
JP2003513756A
(ja)
*
|
1999-11-12 |
2003-04-15 |
アンジオテック ファーマシューティカルズ，インコーポレイテッド |
放射性治療と細胞周期インヒビターとの組合せの組成物
|
|
ATE344801T1
(de)
|
1999-12-29 |
2006-11-15 |
Immunogen Inc |
Doxorubicin- und daunorubicin-enthaltende, zytotoxische mittel und deren therapeutische anwendung
|
|
AU4267700A
(en)
*
|
2000-01-13 |
2001-07-19 |
Academia Sinica |
Application of somatostatin analogs to specific delivery of anti-tumor drugs into tumor cells
|
|
JP2004517034A
(ja)
*
|
2000-04-26 |
2004-06-10 |
バイオシンセマ インコーポレーテッド |
（神経）ペプチド結合ｒｇｄ（ａｒｇ−ｇｌｙ−ａｓｐ）
|
|
US20040170955A1
(en)
|
2000-09-08 |
2004-09-02 |
Wadih Arap |
Human and mouse targeting peptides identified by phage display
|
|
US7420030B2
(en)
|
2000-09-08 |
2008-09-02 |
The Board Of Regents Of The University Of Texas System |
Aminopeptidase A (APA) targeting peptides for the treatment of cancer
|
|
US7452964B2
(en)
|
2001-09-07 |
2008-11-18 |
Board Of Regents, The University Of Texas System |
Compositions and methods of use of targeting peptides against placenta and adipose tissues
|
|
KR100420007B1
(ko)
*
|
2001-04-25 |
2004-03-02 |
노영쇠 |
안트라사이클린 유도체 및 이를 포함하는 항암제
|
|
BR0212897A
(pt)
|
2001-09-21 |
2004-08-24 |
Univ Tulane |
Conjugados de análogos de somatostatina ou bombesina diagnóstica ou terapêutica e usos dos mesmos
|
|
EP1531846A4
(en)
*
|
2002-02-27 |
2006-04-19 |
Us Gov Health & Human Serv |
Conjugates of ligand, linker and cytotoxic agent and related compositions and methods of use
|
|
EP1487493B1
(en)
|
2002-03-01 |
2010-01-20 |
The Administrators of The Tulane Educational Fund |
Conjugates of cytotoxic agents and biologically active peptides
|
|
US7544767B2
(en)
|
2002-04-05 |
2009-06-09 |
Burnham Institute For Medical Research |
HMGN2 peptides and related molecules that selectively home to tumor blood vessels and tumor cells
|
|
WO2003097083A1
(en)
*
|
2002-05-21 |
2003-11-27 |
Daiichi Suntory Pharma Co.,Ltd. |
Medicinal compositions containing ghrelin
|
|
US8313760B2
(en)
|
2002-05-24 |
2012-11-20 |
Angiotech International Ag |
Compositions and methods for coating medical implants
|
|
EP2075014B9
(en)
|
2002-05-24 |
2012-02-01 |
Angiotech International Ag |
Compositions and methods for coating medical implants
|
|
KR20050084599A
(ko)
|
2002-09-26 |
2005-08-26 |
안지오테크 인터내셔날 아게 |
혈관주위 랩
|
|
EP2181704B1
(en)
|
2002-12-30 |
2015-05-06 |
Angiotech International Ag |
Drug delivery from rapid gelling polymer composition
|
|
US20040202666A1
(en)
*
|
2003-01-24 |
2004-10-14 |
Immunomedics, Inc. |
Anti-cancer anthracycline drug-antibody conjugates
|
|
US20050043215A1
(en)
|
2003-02-19 |
2005-02-24 |
Tamara Minko |
Complex drug delivery composition and method for treating cancer
|
|
NZ564694A
(en)
*
|
2003-04-22 |
2009-11-27 |
Sod Conseils Rech Applic |
Peptide vectors
|
|
AU2007221964B2
(en)
*
|
2003-04-22 |
2008-12-11 |
Ipsen Pharma S.A.S. |
Peptide vectors
|
|
US7097993B2
(en)
|
2003-06-25 |
2006-08-29 |
Wisconsin Alumni Research Foundation |
Method for identifying an agent that modulates type 1 phosphatidylinositol phosphate kinase isoform β661 activity
|
|
WO2005086951A2
(en)
*
|
2004-03-10 |
2005-09-22 |
Threshold Pharmaceuticals, Inc. |
Hypoxia-activated anti-cancer agents
|
|
US20070060534A1
(en)
*
|
2005-06-30 |
2007-03-15 |
Threshold Pharmaceuticals, Inc. |
Anthracycline analogs
|
|
JP5340155B2
(ja)
*
|
2006-09-06 |
2013-11-13 |
エテルナ ツェンタリス ゲゼルシャフト ミット ベシュレンクテル ハフツング |
細胞結合分子を有するジソラゾールのコンジュゲート及びそれらの誘導体、新規ジソラゾール誘導体、それらの製法ならびに使用
|
|
EP1900742A1
(en)
|
2006-09-07 |
2008-03-19 |
AEterna Zentaris GmbH |
Conjugates of disorazoles and their derivatives with cell-binding molecules, novel disorazole derivatives, processes of manufacturing and uses thereof
|
|
WO2008100591A2
(en)
*
|
2007-02-14 |
2008-08-21 |
The General Hospital Corporation |
Modulation of nitric oxide signaling to normalize tumor vasculature
|
|
RU2377247C2
(ru)
*
|
2007-12-27 |
2009-12-27 |
Федеральное государственное образовательное учреждение высшего профессионального образования Санкт-Петербургский государственный университет |
Молекулярный конъюгат на основе синтетических аналогов люлиберина и его применение в качестве средства доставки днк в клетки гормон-чувствительных опухолей (варианты)
|
|
US8742076B2
(en)
*
|
2008-02-01 |
2014-06-03 |
Genentech, Inc. |
Nemorubicin metabolite and analog reagents, antibody-drug conjugates and methods
|
|
ES2655243T3
(es)
*
|
2008-04-11 |
2018-02-19 |
Tianjin Hemay Oncology Pharmaceutical Co., Ltd |
Derivados antibióticos de antraciclina con alta actividad, métodos de preparación y usos de los mismos
|
|
WO2009124468A1
(zh)
*
|
2008-04-11 |
2009-10-15 |
天津和美生物技术有限公司 |
具有高活性的四环蒽醌类抗生素的衍生物及其制备和应用
|
|
CN102159248B
(zh)
*
|
2008-07-15 |
2013-09-11 |
健泰科生物技术公司 |
蒽环类衍生物缀合物、它们的制备方法以及它们作为抗肿瘤化合物的用途
|
|
CN102325545A
(zh)
|
2009-02-20 |
2012-01-18 |
益普生制药股份有限公司 |
具有神经肽y受体结合化合物的细胞毒性缀合物
|
|
CN102050856B
(zh)
*
|
2009-11-03 |
2014-04-30 |
天津和美生物技术有限公司 |
具有高活性的表阿霉素的衍生物及其制备和应用
|
|
ES2533710T3
(es)
|
2010-12-02 |
2015-04-14 |
Nerviano Medical Sciences S.R.L. |
Proceso para la preparación de derivados de morfolinil antraciclina
|
|
CN105198966B
(zh)
*
|
2014-06-26 |
2019-06-21 |
中国人民解放军军事医学科学院毒物药物研究所 |
GnRH类似物-细胞毒分子缀合物、其制备方法及用途
|
|
CA2953371C
(en)
*
|
2014-06-30 |
2021-08-24 |
Tarveda Therapeutics, Inc. |
Targeted conjugates and particles and formulations thereof
|
|
EP3045540A1
(en)
|
2015-01-19 |
2016-07-20 |
Æterna Zentaris GmbH |
Enzymatic process for the regioselective manufacturing of N-Fmoc-doxorubicin-14-O-dicarboxylic acid mono esters
|
|
JP7057278B2
(ja)
|
2015-10-28 |
2022-04-19 |
ターベダ セラピューティクス インコーポレイテッド |
Ｓｓｔｒ標的化コンジュゲート及び粒子並びにその製剤
|
|
US10450340B2
(en)
|
2017-02-16 |
2019-10-22 |
Monopar Therapeutics Inc. |
3′-deamino-3′-(2″-pyrroline-1″-yl)-5-imino-13-deoxyanthracyclines and methods of preparation
|
|
WO2021068051A1
(en)
*
|
2018-11-13 |
2021-04-15 |
Provincial Health Services Authority |
Radiolabeled bombesin-derived compounds for in vivo imaging of gastrin-releasing peptide receptor (grpr) and treatment of grpr-related disorders
|
|
CA3246188A1
(en)
|
2022-03-25 |
2023-09-28 |
The University Of British Columbia |
Radiolabeled compounds for in vivo imaging of the gastrin-releasing peptide (GRPR) receptor and treatment of GRPR-related disorders
|